Ann‐Sofie Johansson

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Emanuele Zucca, Stéphanie Rondeau, Anna Vanazzi et al. · Blood · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Blood Erythrocyte Concentrations of Cadmium and Lead and the Risk of B-Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma: A Nested Case-Control Study

Rachel S. Kelly, Thomas Lundh, Miquel Porta et al. · PLoS ONE · 2013 · 30 citations · Full text

Medicine, Hematology, Toxicology +17

Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas

Eva Kimby, Peter de Nully Brown, Hans Hagberg et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 26 citations

Pharmacy, Immunology, Pharmacotherapy +8

Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis

Florentin Späth, Carl Wibom, Esmeralda Krop et al. · Cancer Research · 2017 · 23 citations · Full text

Medicine, Hematology, Oncology +16

No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius et al. · British Journal of Haematology · 2019 · 22 citations

Medicine, Oncology, Radiation Oncology +11